Merit Medical Systems
Stock Forecast, Prediction & Price Target
Merit Medical Systems (MMSI) stock Price Target by analysts
$105.6
Potential upside: 21.17%
Merit Medical Systems price prediction
What is Merit Medical Systems stock analysts` prediction?
Merit Medical Systems stock forecast: Based on 5 Wall Street analysts` predicted price targets for Merit Medical Systems in the last 3 months, the avarage price target is $105.6, with a high forecast of $NaN. The average price target represents a 21.17% change from the last price of $87.15.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Merit Medical Systems stock Price Target by analysts
Full breakdown of analysts given Merit Medical Systems price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Rescott Robert W. Baird | 0% 0/1 | 11 months ago | $107 22.77% upside | $95.52 | StreetInsider | Previous targets (0) |
Mike Matson Needham | 25% 1/4 | 12 months ago | $105 20.48% upside | $96.16 | StreetInsider | Previous targets (3) |
Larry Biegelsen Wells Fargo | 0% 0/2 | 12 months ago | $103 18.18% upside | $96.16 | StreetInsider | Previous targets (1) |
Craig Bijou Bank of America Securities | 0% 0/2 | 12 months ago | $103 18.18% upside | $96.16 | StreetInsider | Previous targets (1) |
Jason Bednar Piper Sandler | 0% 0/3 | 12 months ago | $110 26.21% upside | $96.58 | TheFly | Previous targets (2) |
Craig Bijou Bank of America Securities | 0% 0/2 | about 1 year ago | $92 5.56% upside | $87.44 | StreetInsider | Previous targets (1) |
Jason Bednar Piper Sandler | 0% 0/3 | about 1 year ago | $100 14.74% upside | $86.86 | TheFly | Previous targets (2) |
John Young Canaccord Genuity | 0% 0/1 | about 1 year ago | $125 43.43% upside | $85.64 | TheFly | Previous targets (0) |
Larry Biegelsen Wells Fargo | 0% 0/2 | about 1 year ago | $85 -2.46% downside | $83.25 | StreetInsider | Previous targets (1) |
Jason Bednar Piper Sandler | 0% 0/3 | over 1 year ago | $97 11.30% upside | $77.12 | StreetInsider | Previous targets (2) |
Kristen Stewart C.L. King | 0% 0/1 | over 1 year ago | $88 0.97% upside | $71.95 | TheFly | Previous targets (0) |
Mike Matson Needham | 25% 1/4 | almost 2 years ago | $81 -7.05% downside | $68.83 | Benzinga | Previous targets (3) |
Michael Petusky Barrington | 0% 0/1 | about 2 years ago | $95 9.00% upside | $79.35 | Benzinga | Previous targets (0) |
Mike Matson Needham | 25% 1/4 | about 2 years ago | $96 10.15% upside | $83.81 | Benzinga | Previous targets (3) |
Mike Matson Needham | 25% 1/4 | over 2 years ago | $90 3.27% upside | $81.76 | Benzinga | Previous targets (3) |
Unknown Canaccord Genuity | N/A | about 3 years ago | $69 -20.82% downside | $57.39 | Benzinga | N/A |
Unknown Raymond James | N/A | about 3 years ago | $71 -18.53% downside | $56.8 | Benzinga | N/A |
Merit Medical Systems Financial Estimates
Merit Medical Systems Revenue Estimates
Merit Medical Systems EBITDA Estimates
Merit Medical Systems Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.07B N/A | $1.15B 7.09% | $1.25B 9.24% | Avg: $1.39B Low: $1.38B High: $1.40B avg. 11.04% | Avg: $1.47B Low: $1.46B High: $1.48B avg. 5.63% | Avg: $1.56B Low: $1.55B High: $1.57B avg. 6.09% | Avg: $1.64B Low: $1.64B High: $1.65B avg. 5.42% |
Net Income
% change YoY
| $48.45M N/A | $74.51M 53.78% | $94.41M 26.69% | Avg: $151.52M Low: $124.29M High: $165.73M avg. 60.49% | Avg: $158.87M Low: $138.88M High: $183.82M avg. 4.84% | Avg: $253.84M Low: $252.33M High: $255.27M avg. 59.78% | Avg: $283.90M Low: $282.21M High: $285.49M avg. 11.83% |
EBITDA
% change YoY
| $172.44M N/A | $194.66M 12.88% | $231.44M 18.89% | Avg: $165.44M Low: $164.25M High: $166.15M avg. -28.51% | Avg: $174.76M Low: $173.96M High: $175.51M avg. 5.63% | Avg: $185.40M Low: $184.55M High: $186.20M avg. 6.09% | Avg: $195.45M Low: $194.56M High: $196.30M avg. 5.42% |
EPS
% change YoY
| $0.86 N/A | $1.31 52.32% | $1.64 25.19% | Avg: $2.6 Low: $2.13 High: $2.84 avg. 58.53% | Avg: $2.86 Low: $2.38 High: $3.15 avg. 9.90% | Avg: $4.35 Low: $4.32 High: $4.37 avg. 52.23% | Avg: $4.87 Low: $4.84 High: $4.89 avg. 11.83% |
Operating Expenses
% change YoY
| $406.93M N/A | $418.03M 2.72% | $459.92M 10.02% | Avg: $419.21M Low: $416.21M High: $421.02M avg. -8.85% | Avg: $442.82M Low: $440.80M High: $444.74M avg. 5.63% | Avg: $469.79M Low: $467.65M High: $471.83M avg. 6.09% | Avg: $495.26M Low: $493.00M High: $497.41M avg. 5.42% |
FAQ
What is Merit Medical Systems stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 34.24% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 124.29M, average is 151.52M and high is 165.73M.
What is Merit Medical Systems stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 7.04% in 2025-2028.
We have gathered data from 9 analysts. Their low revenue estimate is $1.38B, average is $1.39B and high is $1.40B.
What is Merit Medical Systems stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 33.12% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $2.13, average is $2.6 and high is $2.84.
What is the best performing analyst?
In the last twelve months 5 analysts have been covering Merit Medical Systems stock. The most successful analyst is David Rescott.